Nancy Beller
Internal Medicine · Mentor, OHNPI 1598864423
Payments from drug & device makers
Across 344 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$722
- Amgen$640
- AstraZeneca$490
- Boehringer Ingelheim$404
- Lilly USA, LLC$386
- Novo Nordisk$385
- plus $2K from 35 others
What the payments were for
- Food & beverage$5,255100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,275 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 14 | $17,093 |
| EliquisApixaban | 23 | $14,853 |
| TrulicityDulaglutide | 15 | $14,689 |
| XareltoRivaroxaban | 14 | $14,438 |
| SymbicortBudesonide/Formoterol Fumarate | 27 | $6,468 |
| Spiriva RespimatTiotropium Bromide | 11 | $5,690 |
| Levothyroxine Sodium | 127 | $1,462 |
| Atorvastatin Calcium | 128 | $1,167 |
| Omeprazole | 71 | $990 |
| Pantoprazole Sodium | 46 | $962 |
| Metoprolol Succinate | 72 | $886 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $782 |
| Ezetimibe | 13 | $752 |
| SynthroidLevothyroxine Sodium | 17 | $740 |
| Pravastatin Sodium | 48 | $680 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $385 | $17,09314 claims |
| PfizerEliquis | $94 | $14,85323 claims |
| Lilly USA, LLCTrulicity | $386 | $14,68915 claims |
| Johnson & JohnsonXarelto | $137 | $14,43814 claims |
| AstraZenecaSymbicort | $490 | $6,46827 claims |
| Boehringer IngelheimSpiriva Respimat | $404 | $5,69011 claims |
| AbbVieSynthroid | $722 | $74017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Mentor
- Daniel WeissMentor$775K
- Antoinette PragalosCincinnati$27.8M
- Steven FolkerthBeavercreek$9.1M
- Charles EgerCincinnati$8.7M
- Vadim KoshkinCleveland$6.1M
- Nizar DaboulMaumee$4.7M
- Douglas LoganCincinnati$4.7M
- Seref BornovaliLoveland$4.4M
- Yevgeniy BukhmanCanton$3.7M
- Leela VrishabhendraCincinnati$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.